Annual EBIT:
$252.84M+$346.50M(+369.98%)Summary
- As of today, PTGX annual earnings before interest & taxes is $252.84 million, with the most recent change of +$346.50 million (+369.98%) on December 31, 2024.
- During the last 3 years, PTGX annual EBIT has risen by +$378.69 million (+300.92%).
- PTGX annual EBIT is now at all-time high.
Performance
PTGX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$42.04M-$22.73M(-117.72%)Summary
- As of today, PTGX quarterly earnings before interest & taxes is -$42.04 million, with the most recent change of -$22.73 million (-117.72%) on June 30, 2025.
- Over the past year, PTGX quarterly EBIT has dropped by -$3.25 million (-8.37%).
- PTGX quarterly EBIT is now -120.38% below its all-time high of $206.31 million, reached on March 31, 2024.
Performance
PTGX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$23.98M-$3.25M(-11.93%)Summary
- As of today, PTGX TTM earnings before interest & taxes is $23.98 million, with the most recent change of -$3.25 million (-11.93%) on June 30, 2025.
- Over the past year, PTGX TTM EBIT has dropped by -$128.26 million (-84.25%).
- PTGX TTM EBIT is now -90.52% below its all-time high of $252.84 million, reached on December 31, 2024.
Performance
PTGX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
PTGX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +370.0% | -8.4% | -84.3% |
| 3Y3 Years | +300.9% | -1.4% | +118.0% |
| 5Y5 Years | +425.4% | -132.5% | +138.7% |
PTGX EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +292.5% | -120.4% | +0.7% | -90.5% | +115.7% |
| 5Y | 5-Year | at high | +292.5% | -120.4% | +0.7% | -90.5% | +115.7% |
| All-Time | All-Time | at high | +292.5% | -120.4% | +0.7% | -90.5% | +115.7% |
PTGX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$42.04M(-117.7%) | $23.98M(-11.9%) |
| Mar 2025 | - | -$19.31M(-115.2%) | $27.22M(-89.2%) |
| Dec 2024 | $252.84M(+370.0%) | $126.78M(+405.8%) | $252.84M(+69.6%) |
| Sep 2024 | - | -$41.45M(-6.9%) | $149.11M(-2.1%) |
| Jun 2024 | - | -$38.79M(-118.8%) | $152.24M(+2.4%) |
| Mar 2024 | - | $206.31M(+795.1%) | $148.68M(+258.8%) |
| Dec 2023 | -$93.65M(+28.7%) | $23.05M(+160.1%) | -$93.65M(+38.9%) |
| Sep 2023 | - | -$38.33M(+9.5%) | -$153.22M(-4.1%) |
| Jun 2023 | - | -$42.35M(-17.6%) | -$147.19M(-0.6%) |
| Mar 2023 | - | -$36.02M(+1.4%) | -$146.28M(-11.3%) |
| Dec 2022 | -$131.37M(-4.4%) | -$36.52M(-13.0%) | -$131.37M(+0.4%) |
| Sep 2022 | - | -$32.30M(+22.1%) | -$131.87M(+1.2%) |
| Jun 2022 | - | -$41.44M(-96.3%) | -$133.50M(-8.6%) |
| Mar 2022 | - | -$21.11M(+43.0%) | -$122.94M(+2.3%) |
| Dec 2021 | -$125.84M(-95.9%) | -$37.02M(-9.1%) | -$125.84M(-17.0%) |
| Sep 2021 | - | -$33.93M(-9.9%) | -$107.59M(-32.2%) |
| Jun 2021 | - | -$30.88M(-28.6%) | -$81.41M(-18.7%) |
| Mar 2021 | - | -$24.02M(-28.1%) | -$68.61M(-6.8%) |
| Dec 2020 | -$64.25M | -$18.76M(-142.2%) | -$64.25M(-3.7%) |
| Sep 2020 | - | -$7.74M(+57.2%) | -$61.96M(+12.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$18.08M(+8.0%) | -$70.73M(+15.2%) |
| Mar 2020 | - | -$19.66M(-19.3%) | -$83.45M(-7.4%) |
| Dec 2019 | -$77.71M(-95.6%) | -$16.48M(+0.2%) | -$77.71M(-4.9%) |
| Sep 2019 | - | -$16.51M(+46.4%) | -$74.10M(-10.6%) |
| Jun 2019 | - | -$30.80M(-121.3%) | -$66.98M(-47.5%) |
| Mar 2019 | - | -$13.92M(-8.2%) | -$45.41M(-14.3%) |
| Dec 2018 | -$39.72M(-7.5%) | -$12.87M(-37.0%) | -$39.72M(-35.0%) |
| Sep 2018 | - | -$9.39M(-1.6%) | -$29.43M(-17.6%) |
| Jun 2018 | - | -$9.24M(-12.3%) | -$25.02M(+19.1%) |
| Mar 2018 | - | -$8.23M(-219.8%) | -$30.91M(+16.4%) |
| Dec 2017 | -$36.96M(-13.1%) | -$2.57M(+48.3%) | -$36.96M(+19.3%) |
| Sep 2017 | - | -$4.98M(+67.1%) | -$45.78M(+4.5%) |
| Jun 2017 | - | -$15.13M(-6.0%) | -$47.94M(-20.2%) |
| Mar 2017 | - | -$14.27M(-25.2%) | -$39.90M(-22.1%) |
| Dec 2016 | -$32.67M(-120.8%) | -$11.40M(-59.7%) | -$32.67M(-24.3%) |
| Sep 2016 | - | -$7.14M(-0.7%) | -$26.27M(-37.3%) |
| Jun 2016 | - | -$7.09M(-0.7%) | -$19.13M(-58.9%) |
| Mar 2016 | - | -$7.04M(-40.8%) | -$12.04M(-56.6%) |
| Dec 2015 | -$14.79M(-58.8%) | -$5.00M(-86.0%) | -$7.69M(-186.0%) |
| Mar 2015 | - | -$2.69M | -$2.69M |
| Dec 2014 | -$9.32M | - | - |
FAQ
- What is Protagonist Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. annual EBIT year-on-year change?
- What is Protagonist Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Protagonist Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Protagonist Therapeutics, Inc.?
- What is Protagonist Therapeutics, Inc. TTM EBIT year-on-year change?
What is Protagonist Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of PTGX is $252.84M
What is the all-time high annual EBIT for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high annual earnings before interest & taxes is $252.84M
What is Protagonist Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, PTGX annual earnings before interest & taxes has changed by +$346.50M (+369.98%)
What is Protagonist Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of PTGX is -$42.04M
What is the all-time high quarterly EBIT for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $206.31M
What is Protagonist Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, PTGX quarterly earnings before interest & taxes has changed by -$3.25M (-8.37%)
What is Protagonist Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of PTGX is $23.98M
What is the all-time high TTM EBIT for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high TTM earnings before interest & taxes is $252.84M
What is Protagonist Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, PTGX TTM earnings before interest & taxes has changed by -$128.26M (-84.25%)